Xing-Sheng Shu (Xingsheng Shu)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 11

Top Topics

Minimally Invasive

Genome Wide Identification

Top Venues

Cell death & disease

Cancer research

Proceedings of the National Academy of Sciences of the United States of America

This page only lists publications with an associated author ORCID identifier.

Publications

Yongheng Chen, Ying Ying, Wenlong Ma, Hongchao Ma, Liang Shi, Xuefeng Gao, Min Jia, Meiqi Li, Xiaoman Song, Weixiao Kong, Wei Chen, Xiangyi Zheng, Tobias Achu Muluh, Xiaobin Wang, Maolin Wang, Xing-Sheng Shu
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression. Cancer research 84 (8) (2024)
Yongheng Chen, Ying Ying, Wenlong Ma, Hongchao Ma, Liang Shi, Xuefeng Gao, Min Jia, Meiqi Li, Xiaoman Song, Weixiao Kong, Wei Chen, Xiangyi Zheng, Tobias Achu Muluh, Xiaobin Wang, Maolin Wang, Xing-Sheng Shu
Targeting the epigenetic reader ENL inhibits super-enhancer-driven oncogenic transcription and synergizes with BET inhibition to suppress tumor progression. Cancer research (2024)
Yongheng Chen, Ying Ying, Wenlong Ma, Hongchao Ma, Liang Shi, Xuefeng Gao, Min Jia, Meiqi Li, Xiaoman Song, Weixiao Kong, Wei Chen, Xiangyi Zheng, Tobias Achu Muluh, Xiaobin Wang, Maolin Wang, Xing-Sheng Shu
Targeting the Epigenetic Reader ENL Inhibits Super-Enhancer-Driven Oncogenic Transcription and Synergizes with BET Inhibition to Suppress Tumor Progression. Cancer research 84 (8) (2024)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Yongheng Chen, Ying Ying, Maolin Wang, Canjie Ma, Min Jia, Liang Shi, Shilan Wang, Xiangyi Zheng, Wei Chen, Xing-Sheng Shu
A distal super-enhancer activates oncogenic ETS2 via recruiting MECOM in inflammatory bowel disease and colorectal cancer. Cell death & disease 14 (1) (2023)
Ying Ying, Maolin Wang, Yongheng Chen, Meiqi Li, Canjie Ma, Junbao Zhang, Xiaoyan Huang, Min Jia, Junhui Zeng, Yejun Wang, Lili Li, Xiaomei Wang, Qian Tao, Xing-Sheng Shu
Zinc finger protein 280C contributes to colorectal tumorigenesis by maintaining epigenetic repression at H3K27me3-marked loci. Proceedings of the National Academy of Sciences of the United States of America 119 (22) (2022)
Fangfei Xiao, Xuefeng Gao, Hui Hu, Jun Le, Yongheng Chen, Xing-Sheng Shu, Ziwei Liang, Yang Xu, Yizhong Wang, Ting Zhang
Exclusive Enteral Nutrition Exerts Anti-Inflammatory Effects through Modulating Microbiota, Bile Acid Metabolism, and Immune Activities. Nutrients 14 (21) (2022)
Xing-Sheng Shu, Yingying Zhao, Yanmei Sun, Lan Zhong, Yingduan Cheng, Yixiang Zhang, Kaile Ning, Qian Tao, Yejun Wang, Ying Ying
The epigenetic modifier PBRM1 restricts the basal activity of the innate immune system by repressing retinoic acid-inducible gene-I-like receptor signalling and is a potential prognostic biomarker for colon cancer. The Journal of pathology 244 (1) (2017)